Analyzing data from The Cancer Genome Atlas (TCGA), Clinical Proteomic Tumor Analysis Consortium (CPTAC), and The Human Protein Atlas (26–28), this study shows that EHHADH expression is reduced in ccRCC and correlates with patient survival. Here, EHHADH is linked to nonpapillary renal cell carcinoma.